TheCD4+AT2R+T cell subpopulation improves post‐infarction remodelling and restores cardiac function
Key result
Intramyocardial injection of MI-induced splenic CD4+ AT2R+ T cells into recipient rats with myocardial infarction reduced infarct size and improved cardiac performance.
Why the study?
Does intramyocardial injection of CD4+ AT2R+ T cells improve cardiac function and reduce infarct size in a rat model of myocardial infarction?
Population
Rodent model of heart failure (myocardial infarction) and human heart failure patients with healthy controls
Design
Preclinical
Authors
Discussion
Loading...
Member takes
Implication
May support preclinical T-cell therapy exploration post-MI; leaves open human translation.
Structured PICO
Does intramyocardial injection of CD4+ AT2R+ T cells improve cardiac function and reduce infarct size in a rat model of myocardial infarction?
P
Population
Rodent model of heart failure (myocardial infarction) and human heart failure patients with healthy controls
I
Intervention
Intramyocardial injection of MI-induced splenic CD4+ AT2R+ T cells
O
Outcome
Infarct size and cardiac performancesurrogate
CD4+ AT2R+ T cells represent a potential regenerative therapy target for improving heart function and reducing infarct size post-myocardial infarction.
Cite This Study
Skorska et al. (2015) studied Myocardial infarction and heart failure. Intramyocardial injection of CD4+ AT2R+ T cells was evaluated on Infarct size and cardiac performance. Intramyocardial injection of MI-induced splenic CD4+ AT2R+ T cells into recipient rats with myocardial infarction reduced infarct size and improved cardiac performance.